07.25.25 -- A New Prescription For R&D Tax Credit Reporting

Whether on the verge of a new product approval or approaching maximum production capacity, a business expansion may be in your future. Learn about resources, timelines, and top considerations.

For early-stage biotech companies, the road from discovery to market is fraught with challenges, and in this environment, strategic partnerships with CROs have become a cornerstone of clinical success.

Unlike traditional drugs, AAV therapies require extensive characterization and testing, demanding varying degrees of analysis at each stage of development.

A client was falling behind on timelines and unable to increase headcount. The churn of using temporary employees was having a negative impact on the morale of their FTEs. Find the solution.

Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

Collaboration between drug development companies and Patient Advocacy Organizations is essential to bridging gaps between stakeholders and advancing rare disease research.